STDs
As the pandemic continues to play out, test developers aren't sure how it will impact STIs and their work around developing and manufacturing tests.
CDC Updates STI Diagnosis, Treatment Guidelines
The new guidelines include recommendations for molecular testing in suspected cases of Mycoplasma genitalium and bacterial vaginosis.
Binx Health Raises $104M in Series E Round
The Boston-based company said it will use the funds to ramp up manufacturing of its FDA-cleared Binx io molecular point-of-care instrument, among other things.
Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease
In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.
SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey
The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance.
Apr 30, 2020
FDA Provides Second Clearance for Binx MDx Platform
Mar 4, 2020
Randox Laboratories STI Assay Gets CE Mark
Feb 11, 2020
SpeeDx Raises Additional $15M
Jan 13, 2020
SpeeDx, LabCorp Will Codevelop MDx Tests
Nov 14, 2019
Linear Diagnostics Lands £2M Investment
Oct 15, 2019
Enzo Biochem Fiscal Q4 Revenues Down 8 Percent
Aug 5, 2019